Drug
albumin 20%
albumin 20% is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
50%(1 trials)
Phase Distribution
Ph phase_4
3
75%
Ph phase_2
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
3
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 4Post-market surveillance
3(75.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(2)
Other(1)
Detailed Status
Completed2
unknown1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (25.0%)
Phase 43 (75.0%)
Trials by Status
unknown125%
completed250%
recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
recruitingphase_4
Fluid Challenge and Plasma Volume, During Surgery
NCT05726136
completedphase_4
Impact of Hyperoncotic Albumin to Support Blood Loss Replacement
NCT03848507
completedphase_2
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
NCT01561053
unknownphase_4
Volume Kinetics for 20% Albumin in Different Clinical Situations
NCT02556580
Clinical Trials (4)
Showing 4 of 4 trials
NCT05726136Phase 4
Fluid Challenge and Plasma Volume, During Surgery
NCT03848507Phase 4
Impact of Hyperoncotic Albumin to Support Blood Loss Replacement
NCT01561053Phase 2
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
NCT02556580Phase 4
Volume Kinetics for 20% Albumin in Different Clinical Situations
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4